Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: Re: Exercisable options
14
Aug 17, 2019 11:57AM
10
Aug 17, 2019 12:24PM
4
Aug 17, 2019 12:39PM
28
Aug 17, 2019 12:44PM
8
TKB
Aug 17, 2019 02:09PM
3
Aug 17, 2019 02:43PM
10
Aug 17, 2019 02:49PM

Aug 17, 2019 03:16PM
19
Aug 17, 2019 03:46PM
2
Aug 17, 2019 04:17PM
2
Aug 17, 2019 04:26PM
11
Aug 17, 2019 04:31PM

 TKB wrote: The options granted have a vesting date and expiration date. One cannot buy before the vesting date or after expiration date

This was in response to 1998BMWZ3: According to the Annual Report there are over 16 million exercisable options within 60 days of the report. A few have dropped off in July and August. Most are in the range of $1.40 and $1.54. Half drop off as of next June. Suresh has 6.4 million of those. 

So just to be clear it would be great in the future if instead of putting out a statement for all the readers here in which might suggest that those options may not be exercisable or may have expired you could check the way I did and let the form know that yes those options are vested and available until 2020. It’s not that hard to be heard if you do a little bit of work. Is that fair? I think so. You know it is disappointing to me to see a couple of really negative posts here today. It is great to have Oz back but it is a shame he has to read what appears to  be a total  lack  of  awareness  of the great due diligence that has been provided here and especially with Oz being such a big part of this. I am reading Doubts post and wondering if he has completely missed what the company has been doing in regard to DenseLight or if truly does not know? Without DenseLight they would never have achieve the R&D what SV has referred to the Heavy Lifting to bring the dielectric Optical Interposer platform to commercial readiness in such short time frame.

https://www.sec.gov/Archives/edgar/data/1437424/000117184317002153/f20f_041717.htm

https://docs.google.com/spreadsheets/d/1_6VSZGqigLbjQyh_LJxMfpa4fc7pTbaj_8wtvRVDEW0/edit#gid=2028980574

Dr. Venkatesan was granted 6,357,082 options to purchase common shares of the company. The options may be exercised at a price of $1.40 per share for a term of five years from the effective date of his employment, expiring on June 10, 2020. The option terms were determined based on current market price in accordance with the TSX Venture Exchange policies and the company's stock option plan and the options will vest as follows: 908,154 options on the first anniversary of the effective date, 681,116 options on the 18th month anniversary of the effective date, 681,116 options on the 24th month anniversary of the effective date, and 1,021,674 options on the 30th, 36th, 42nd and 48th month anniversary of the effective date.

 

3
Aug 17, 2019 05:02PM
10
Aug 17, 2019 05:07PM
18
Aug 17, 2019 05:10PM
11
Aug 17, 2019 05:55PM
2
Aug 17, 2019 05:56PM
5
Aug 17, 2019 07:24PM
10
Aug 17, 2019 07:29PM
4
Aug 17, 2019 09:26PM
3
Aug 17, 2019 11:59PM
7
Aug 18, 2019 12:24AM
3
Aug 18, 2019 12:25AM
28
Aug 18, 2019 02:44AM
10
TKB
Aug 18, 2019 11:29AM
13
Aug 18, 2019 11:51AM
25
Aug 18, 2019 04:33PM
Share
New Message
Please login to post a reply